XLV vs IXJ
YTDYear to date
XLV wins+4.4 pts
Past year
XLV wins+5.0 pts
Fee
XLV winslower fee
Yield
XLV wins+0.1 pts
AUM
XLV10.7× more
4–0XLV wins
XLV and IXJ · year-to-date · as of Nov 4, 2026 · AUM not scored
IXJ vs XLV
YTD$111.96 · −0.5% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareXLV+ S&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return−0.5%+10.3%+10.8%+16.0%+24.7%+49.6%+38.2%+462.6%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
iShares IXJ and XLV · total return, dividends in · as of Nov 4, 2026
IXJ’s Holdings
TodayLLYEli Lilly11.6%JNJ6.7%ABBV5.3%MRK4.2%UNH4.1%ROP.SW3.9%NOVN.SW3.4%AZN.L3.3%TMO2.9%AMGN2.8%GILD2.4%ABT2.1%PFE2.0%ISRG1.7%DHR1.6%VRTX1.6%BMY1.4%NOVO-B.CO1.4%MDT1.3%MCK1.3%87 more
LLYEli Lilly11.6%JNJ6.7%ABBV5.3%MRK4.2%UNH4.1%ROP.SW3.9%NOVN.SW3.4%AZN.L3.3%TMO2.9%AMGN2.8%GILD2.4%97 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
iShares IXJ · 109 holdings · tile size = share of the fund · as of Nov 3, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.4% | +20.4% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.6% | +19.6% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +27.2% | +27.2% | $10.5B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +19.8% | +19.8% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +16.0% | +16.0% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −8.9% | −8.9% | $3.9B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.7% | +19.7% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +70.9% | +70.9% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.9% | +26.9% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.7% | +24.7% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.5% | +22.5% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +33.8% | +33.8% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +21.8% | +21.8% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.0% | +17.0% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +24.5% | +24.5% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +35.0% | +35.0% | $525M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 4, 2026
IXJ Payouts by Year
13YLatest payout, Jun 2026
$0.85
a share · twice a year
1.3% yield
1.3% yield
13 years added up
$13.64 a share
$13.64 a share
iShares IXJ · per-share distributions by ex-date · 2014–2026
IXJ’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −0.3% | +20.4% | +29.7% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −0.1% | +19.6% | +28.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +1.9% | +27.2% | +38.1% | $10.5B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.4% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFThis fund | 0.38% | 1.3% | −0.5% | +16.0% | +24.7% | $4.6B | |
| 6 | IHI | iShares U.S. Medical Devices ETFReadVersus | 0.37% | 0.5% | −0.1% | −8.9% | −5.8% | $3.9B |
#22 of 33 this year · #19 cheapest of 39 · sorted by assetsOpen the Sectors table →
IXJ and its peer group · total return · as of Nov 4, 2026
Cards for This View
IXJ’s Top 10 Holdings
Today48.2%of IXJ sits in these 10
7NOVN.SNovartis Ag3.36%
iShares IXJ · weight in the fund · as of Nov 3, 2026
IXJ’s Holdings
TodayLLYEli Lilly11.6%JNJ6.7%ABBV5.3%MRK4.2%UNH4.1%ROP.SW3.9%NOVN.SW3.4%AZN.L3.3%TMO2.9%AMGN2.8%GILD2.4%ABT2.1%PFE2.0%ISRG1.7%DHR1.6%VRTX1.6%BMY1.4%NOVO-B.CO1.4%MDT1.3%MCK1.3%87 more
LLYEli Lilly11.6%JNJ6.7%ABBV5.3%MRK4.2%UNH4.1%ROP.SW3.9%NOVN.SW3.4%AZN.L3.3%TMO2.9%AMGN2.8%GILD2.4%97 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
iShares IXJ · 109 holdings · tile size = share of the fund · as of Nov 3, 2026
IXJ vs Peer Average
YTDIXJAvsBPeer average
1D−0.5%+0.6%
1M+10.3%+4.0%
3M+10.8%+6.1%
YTD+16.0%+21.0%
1Y+24.7%+29.0%
3Y+49.6%+81.2%
5Y+38.2%+28.9%
3–4Peer average wins
38 Health care peers · each row scaled to its leader